Tricyclics, tenapanor (Ibsrela), and alosetron (Lotronex) for irritable bowel syndrome (IBS) were associated with a higher ...

After emerging on the scene in the early 2000s, fracture liaison services (FLS) have solidified their place for preventing ...

An osteoanabolic agent should be the first choice treatment for patients at high or imminent risk for fracture, but once ...

The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and ...